Perimeter Medical Imaging AI, Inc. announced the initiation of an additional clinical trial site at the University of Washington /Fred Hutch Cancer Center located in Seattle, WA. Perimeter is conducting an ongoing multi-center, randomized two-arm pivotal clinical trial evaluating the investigational Perimeter B-Series OCT combined with its proprietary ImgAssist AI software when used during breast conservation surgeries.
Perimeter Medical Imaging AI, Inc.
Equities
PINK
CA71385D1078
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7 CAD | +1.45% | -9.09% | -42.62% |
Apr. 22 | Perimeter Medical Imaging AI, Inc.(TSXV:PINK) dropped from S&P/TSX Venture Composite Index | CI |
Apr. 16 | Transcript : Perimeter Medical Imaging AI, Inc. - Special Call |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.62% | 33.26M | |
-5.77% | 14.68B | |
-40.71% | 2.71B | |
-12.92% | 2.44B | |
-8.78% | 1.51B | |
-.--% | 1.12B | |
+40.66% | 518M | |
+91.79% | 502M | |
+11.68% | 239M | |
+1.67% | 183M |
- Stock Market
- Equities
- PINK Stock
- News Perimeter Medical Imaging AI, Inc.
- Perimeter Medical Imaging AI, Inc. Announces Initiation of Additional Clinical Trial Site at University of Washington / Fred Hutch Cancer Center Located in Seattle, WA